Literature DB >> 14701665

Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.

Kenneth Feingold1, Min Sun Kim, Judy Shigenaga, Art Moser, Carl Grunfeld.   

Abstract

Severe sepsis results in the decreased uptake and oxidation of fatty acids in the heart and cardiac failure. Some of the key proteins required for fatty acid uptake and oxidation in the heart have been shown to be downregulated after endotoxin (LPS) administration. The nuclear hormone receptors, peroxisome proliferator-activated receptor (PPAR) and thyroid receptor (TR), which heterodimerize with the retinoid X receptor (RXR), are important regulators of fatty acid metabolism and decrease in the liver after LPS administration. In the present study, we demonstrate that LPS treatment produces a rapid and marked decrease in the mRNA levels of all three RXR isoforms, PPARalpha and PPARdelta, and TRalpha and TRbeta in the heart. Moreover, LPS administration also decreased the expression of the coactivators CREB-binding protein (CBP)/p300, steroid receptor coactivator (SRC)-1, SRC-3, TR-associated protein (TRAP)220, and PPARgamma coactivator (PGC)-1, all of which are required for the transcriptional activity of RXR-PPAR and RXR-TR. In addition, the mRNA levels of the target genes malic enzyme, Spot 14, sarcoplasmic reticulum Ca2+-ATPase, or SERCA2, the VLDL receptor, fatty acyl-CoA synthetase, fatty acid transporter/CD36, carnitine palmitoyltransferase Ibeta, and lipoprotein lipase decrease in the heart after LPS treatment. The decrease in expression of RXRalpha, -beta, and -gamma, PPARalpha and -delta, and TRalpha and -beta, and of the coactivators CBP/p300, SRC-1, SRC-3, TRAP220, and PGC-1 and the genes they regulate, induced by LPS in the heart, could account for the decreased expression of key proteins required for fatty acid oxidation and thereby play an important role in cardiac contractility. These alterations could contribute to the myocardial dysfunction that occurs during sepsis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14701665     DOI: 10.1152/ajpendo.00205.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  58 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

Review 2.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

3.  Toll-like receptor 4 modulates skeletal muscle substrate metabolism.

Authors:  Madlyn I Frisard; Ryan P McMillan; Julie Marchand; Kristin A Wahlberg; Yaru Wu; Kevin A Voelker; Leonie Heilbronn; Kimberly Haynie; Brendan Muoio; Liwu Li; Matthew W Hulver
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-23       Impact factor: 4.310

4.  High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.

Authors:  Amar B Singh; Rakeshwar S Guleria; Irina T Nizamutdinova; Kenneth M Baker; Jing Pan
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

5.  Fight fat with DGAT.

Authors:  Rinke Stienstra; Sander Kersten
Journal:  J Lipid Res       Date:  2011-01-28       Impact factor: 5.922

6.  PGC-1α expression is increased in leukocytes in experimental acute pancreatitis.

Authors:  Flávia Llimona; Thais Martins de Lima; Ana Iochabel Moretti; Mariana Theobaldo; Jose Jukemura; Irineu Tadeu Velasco; Marcel C C Machado; Heraldo Possolo Souza
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

7.  Nonhematopoietic Peroxisome Proliferator-Activated Receptor-α Protects Against Cardiac Injury and Enhances Survival in Experimental Polymicrobial Sepsis.

Authors:  Stephen W Standage; Rachel L Waworuntu; Martha A Delaney; Sara M Maskal; Brock G Bennion; Jeremy S Duffield; William C Parks; W Conrad Liles; John K McGuire
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

Review 8.  Molecular determinants of the cardiometabolic phenotype.

Authors:  Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

9.  Metformin protects against infection-induced myocardial dysfunction.

Authors:  Theodora Tzanavari; Aimilia Varela; Stamatis Theocharis; Elpinickie Ninou; Alkistis Kapelouzou; Dennis V Cokkinos; Maria I Kontaridis; Katia P Karalis
Journal:  Metabolism       Date:  2016-07-09       Impact factor: 8.694

10.  Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm.

Authors:  Kenneth R Feingold; Arthur Moser; Sophie M Patzek; Judy K Shigenaga; Carl Grunfeld
Journal:  J Lipid Res       Date:  2009-05-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.